Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A/B vaccination in HIV patients with adjunctive interleukin-2
2005-002171-33Phase 4Terminated
- Sponsor
- Aalborg University Hospital
- Start
- Jul 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of hepatitis b vaccine recombinant and aldesleukin in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Antibody response after 3 Twinrix injections. Started Jul 2005; status: terminated.
02
Drugs
hepatitis b vaccine recombinantaldesleukin
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-002171-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002171-33.